Quercetin pretreated umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease via IL-10 /Janus kinase 2/STAT3 signaling

doi:10.4252/wjsc.v17.i9.105896

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

This Article

(52)

(59)

(0)

(15)

(908)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Stem Cells. Sep 26, 2025; 17(9): 105896
Published online Sep 26, 2025. doi: 10.4252/wjsc.v17.i9.105896

Full Size Figure Download Figure

Figure 1 Isolation and identification of human umbilical cord-derived mesenchymal stem cells. A: Human umbilical cord-derived mesenchymal stem cell (hUCMSC) morphology. Scale bar = 100 μm; B: Detection of surface markers of hUCMSCs by flow cytometry; C: HUCMSCs differentiate into osteoblasts. Scale bar = 500 μm; D: HUCMSCs differentiate into adipocytes. Scale bar = 500 μm.

Citation: Shi MY, Liu L, Yang FY. Quercetin pretreated umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease via IL-10 /Janus kinase 2/STAT3 signaling. World J Stem Cells 2025; 17(9): 105896
URL: https://www.wjgnet.com/1948-0210/full/v17/i9/105896.htm
DOI: https://dx.doi.org/10.4252/wjsc.v17.i9.105896

Shi MY, Liu L, Yang FY. Quercetin pretreated umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease via IL-10 /Janus kinase 2/STAT3 signaling. World J Stem Cells 2025; 17(9): 105896 [PMID: 41025102 DOI: 10.4252/wjsc.v17.i9.105896]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.